16 articles for A Vakalopoulos
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
38
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.

Bayer Pharmaceuticals
32
Novel tetrahydrochinoline derived CETP inhibitors.

Bayer Healthcare
41
Discovery of BAY 3389934 Hydrochloride: A Potent and Selective Small-Molecule Dual Factor IIa/Xa Inhibitor with Short Half-Life for the Acute Treatment of Sepsis-Induced Coagulopathy.

Germany.F. Hoffmann-La Roche Ltd
31
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance.

Bayer AG
28
Dibenzodioxocinones--a new class of CETP inhibitors.

Bayer Healthcare Pharma Research
4
OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

Columbia University
17
Haematopoietic-prostaglandin D2 synthase inhibitors

The University of Queensland
270
Substituted imidazopyridines as HDM2 inhibitors

Merck Sharp & Dohme
51
Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Novartis
7
M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder.

Temple University
14
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor.

Uppsala University
3
The C-terminal domain of the mGluR1 metabotropic glutamate receptor affects sensitivity to agonists.

Cns Research
11
Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

University of Toronto
7
Inhibitor specificity via protein dynamics: insights from the design of antibacterial agents targeted against thymidylate synthase.

UniversitÀ